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Objective: Frontal and/or temporal lobar atrophy (F/TA) is sometimes detected on neuroimaging 
in patients with psychiatric disease. This observation leads to difﬁ  culty in distinguishing 
whether patients have fronto-temporal dementia (FTD) or psychiatric illness. This paper sets 
out to develop clinical proﬁ  les that might be useful at ﬁ  rst presentation to distinguish these 
two populations.
Methods: 29 patients were selected from a database of 250 current patients attending young 
onset dementia clinic. Control and experimental patient groups were established using DSM-5 
criteria: (i) those without selective atrophy who had a psychiatric disorder (N = 5); (ii) patients 
who had FTD using consensus criteria (N = 13); and (iii) an experimental group of patients 
who had F/TA on neuroimaging, a psychiatric diagnosis and referral with possibility of a 
neurodegenerative disorder (N = 11). Proﬁ  les suggestive of FTD and psychiatric disease were 
established in the control groups utilising information from medical records, the neurological 
examination, the natural history and neuropsychometry to develop criteria to distinguish reliably 
FTD from psychiatric disease. These criteria were then applied to the experimental group. 
Patients were followed for ﬁ  ve years.
Results: The developed criteria resulted in 3 patients being classiﬁ  ed as FTD and 8 having 
psychiatric diagnoses in the experimental group. At follow-up, all the psychiatric patients 
remained functionally stable, whereas the FTD patients had deteriorated.
Conclusion: Characteristic proﬁ  les may prove useful in the diagnosis of patients with F/TA 
on imaging with a psychiatric illness and help to distinguish them from patients with FTD. At 
ﬁ  rst presentation F/TA has been found in some patients with psychiatric disease who do not 
develop evidence of neurodegeneration. This suggests that F/TA on neuroimaging might be a 
feature of a subgroup of patients with psychiatric diseases.
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Introduction
The difﬁ  culty of distinguishing psychiatric disorders from early neurodegenerative 
processes such as fronto-temporal dementia (FTD) relates to many factors, including 
comorbidity and the utility of consensus criteria and neuroimaging results.
While the presence of selective frontal and/or temporal atrophy is often associated 
with FTD, it can also exist in psychiatric conditions, and thus is of limited used 
diagnostically. A diagnosis of FTD is often based on behavioural changes (Pasquier 
et al 1998), however in the early stages, the paucity of obvious signs and symptoms 
may also hinder diagnosis (Mendez and Perryman 2002). Furthermore, psychiatric 
symptomatology often co-exists with FTD (Gregory 1999).
With the aim of assisting the clinician in distinguishing patients with early FTD 
from those with a psychiatric disorder, when frontal and/or temporal lobe atrophy is 
evident on imaging, this study outlines the development of comparative proﬁ  les of Neuropsychiatric Disease and Treatment 2007:3(5) 638
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suggestive signs, symptoms and neuropsychometric results 
for patients with early FTD or psychiatric disorders.
Materials and methods
Participants
Twenty-nine participants were selected from a database 
of 250 patients currently attending or having previously 
attended the early onset dementia clinic at the Neurosciences 
Unit since its inception, 7 years prior. All individuals were 
referred to the senior author (PKP) for neurological exami-
nation from various general practitioners, neurologists, psy-
chiatrists and other professional organisations. Two control 
groups and an experimental group were formed according 
to the following criteria. Inclusion in the psychiatric control 
group (CPsy) was dependent on (1) the presence of a psy-
chiatric disorder conforming to the DSM-5 criteria, (2) the 
fact that FTD had been raised as possibility, leading to a 
neurology referral, and (3) no evidence of selective atrophy 
on neuroimaging. The FTD control group (CFtd) partici-
pants were required to have (1) a diagnosis of sporadic FTD 
based on the consensus criteria (Neary et al 1998), and (2) 
evidence of selective frontal and/or temporal lobar atrophy 
on imaging. Criteria for entry into the experimental group 
consisted of (1) atrophy on imaging suggestive of FTD and 
(2) referral to the Neurosciences Unit for elucidation of the 
diagnosis due to diagnostic uncertainty between FTD and 
psychiatric disorder. Demographic information for these 
groups is presented in Table 1.
Procedure
Patient ﬁ  les from the two control groups were reviewed, and 
the following information was extracted: patient demograph-
ics, details of clinical history provided at ﬁ  rst presentation to 
the clinic, the results from presenting clinical examination, 
and neuropsychological data gathered at time of referral.
All neuroimaging results had been evaluated by senior 
radiologists without prior knowledge of the nature of the 
study, and were performed using conventional computerised 
tomography (CT) or magnetic resonance imaging (MRI) 
techniques.
Selected results from exhaustive neuropsychological 
assessment were also reviewed. Choice of neuropsychometric 
measures to be addressed was driven by two factors: those 
tests used most extensively in neuropsychological assess-
ments conducted at the unit, and those considered sensitive 
to frontal and temporal lobe dysfunction. Several memory 
and executive function measures were chosen on the basis of 
these criteria including the Rey Complex Figure Test (CFT) 
(Rey 1964), the Rey Auditory Verbal Learning Test (RAVLT) 
(Rey 1941) and the Controlled Oral Word Association Test 
(COWAT, or FAS; Benton and Hamsher 1989). Subtest 
and summary scores from the Wechsler Adult Intelligence 
Scale-Third Edition (WAIS-III) (Wechsler 1997) were used 
as a measure of overall intelligence. Results for the copy and 
3-minute recall trials for the CFT were scored according to 
published norms (Boone et al 1993), as were scores from the 
RAVLT (Geffen 1995), and the FAS (Tombaugh et al 1999). 
A recently published meta-analysis of neuropsychological 
outcome of FTD listed the COWAT, WAIS measures, RCF 
and RAVLT as differentiating between controls and FTD 
patients with effect sizes ranging from moderate to extremely 
high (Zakzanis 1998).
Using normative data as a reference, the number of 
standard deviations from the age appropriate normal 
mean was calculated for each patient’s result to render 
the ﬁ  ndings comparable. These were then averaged within 
each control group. WAIS-III Performance, Verbal and 
Full Scale IQ summary scores as well as age-adjusted 
scaled subtest scores were averaged within groups for 
comparison. This method is not presented as being statisti-
cally rigorous. Data was assessed at the level of trends, 
rather than statistical signiﬁ  cance. Therefore, descriptive 
terminology (based on that suggested in the WAIS-III 
manual; Wechsler 1997) is presented instead of numeri-
cal score values.
By reviewing the aforementioned information and data, 
proﬁ  les of characteristics were generated for both control 
groups. The resultant proﬁ  les were then used to classify 
individuals in the experimental group as having a diagnosis 
of psychiatric disorder or FTD.
The resultant proﬁ  les were then used to classify individual 
patients as having a diagnosis of psychiatric disorder or FTD. 
The details of the experimental group proﬁ  le, the analysis in 
each patient and the conclusion in each patient are contained 
in the Results section. The more detailed clinical histories 
are contained in Appendix A.
Table 1 Demographic details for the experimental and control 
groups (Psychiatric and FTD)
Group  N  Mean age  N male  N female
   (years)
Control
 Psychiatric  5  50.2  3  2
 FTD  13  58  7  6
Experimental 11  59.3  5  6Neuropsychiatric Disease and Treatment 2007:3(5) 639
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Independent veriﬁ  cation of the experimental group was 
obtained after review by a psychiatrist who conﬁ  rmed the 
psychiatric diagnoses in our patients labelled as psychiatric 
disorder in the experimental group and as FTD by a neurolo-
gist after ﬁ  ve years of follow-up. Further veriﬁ  cation was 
obtained by examination of the natural history in which 
patients with psychiatric diseases remain relatively stable at 
5 years, whereas those with FTD had deteriorated.
Results
The following describes a summary of the presentation of 
both control groups on initial examination.
Referral source and reason for referral
As expected, CPsy participants were most often referred from 
psychiatry, whereas CFtd participants were more likely to 
be referred by their general practitioners. Both groups were 
most commonly referred due to suggestive neurology.
Presenting complaints
The most frequent presenting complaints of CPsy participants 
were found to be social withdrawal, poor short-term memory, 
whereas CFtd individuals were more often unable to provide 
a history, and reported problems with attention, concentration, 
memory and depression, but were less likely to complain of 
withdrawal. Reports of social withdrawal described by the 
patients were conﬁ  rmed by informants such as the patient’s 
spouse or carer. There seemed to be no differences insight 
between the psychiatric group and those with FTD as con-
ﬁ  rmed by interview of the patients, spouses or carers.
History of neurological/psychiatric 
symptoms
A large percentage of the CPsy group experienced onset of 
psychiatric symptoms prior to neurological problems. The 
CFtd group was more likely to have not experienced any 
preceding psychiatric symptomatology whereas individu-
als in CPsy reported the presence of a range of psychiatric 
factors.
History of neuroactive medication use
Antidepressant prescription was common in both groups 
(CPsy: 80%; CFtd: 46%), however, most CFtd individuals 
had no history of neuroactive medication use.
Medical/psychiatric history
Most CFtd participants (69%) reported no signiﬁ  cant past 
medical or psychiatric history, while the majority of the CPsy 
group reported signiﬁ  cant psychiatric histories, including 
depression in 80% of cases.
Family history
The families of the CPsy patients were found to have histories 
of depression, alcoholism, and bipolar affective disorder, in 
contrast to the CFtd group, where signiﬁ  cant family history 
of dementia in both ﬁ  rst and second-degree relatives was 
noted. These families were also more likely to have motor 
neurone disease in their lineage or no relevant family history 
than to have a positive psychiatric history.
Forensic/compensation issues
There were no positive forensic histories or workers com-
pensation claims in the CFtd group. In the CPsy group, 40% 
were claiming worker’s compensation.
Family report on patient status
on presentation
The families of CPsy participants were most likely to com-
plain of excessive anger, whereas those of CFtd participants 
more commonly noted poor memory, disinhibition, and 
social withdrawal among numerous other symptoms in their 
relatives.
Professional’s report on patient status
on presentation
Professional reports of patients’ behaviours revealed a similar 
pattern, with poor memory, depression, and evidence of fron-
tal lobe syndrome most commonly present in both groups. 
However, unlike those in the CFtd group, CPsy patients were 
more frequently considered to display communicative dif-
ﬁ  culties in terms of impaired comprehension or aphasia.
Results of neurological examination
With the exception of complaints of poor working and 
semantic memory, the individuals in the CPsy group did not 
demonstrate positive signs on neurological examination. In 
contrast, the signs noted on examination of the CFtd group 
were wide ranging. The CFtd individuals demonstrated eye 
movement abnormalities, abnormal reﬂ  exes, posture, gait and 
involuntary movements, frontal lobe release signs, abnormal 
executive functions and a poorer performance than the CPsy 
group on bedside memory tests of autobiographical and 
semantic memory (but not for working memory). None of the 
CPsy group were found to have extrapyramidal signs or signs 
of motor neurone disease at presentation or at subsequent 
reviews, whereas one patient in the CFtd group developed Neuropsychiatric Disease and Treatment 2007:3(5) 640
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signs consistent with anterior horn disease, and three dis-
played extrapyramidal signs. Rigidity was tested at rest and 
with contralateral augmentation. There was no evidence of 
oppositional or facilitatory paratonia in our patients.
Natural history
None of our patients died during the study and neuropatho-
logical examination was therefore not possible. Twenty-nine 
patients in total within the control and experimental groups in 
this study were followed for 5 years and the results of those 
patients only are included. No patients were lost to follow-up 
in the study and in general patients in the CPsy group had 
a ﬂ  uctuation course and some showed improvement. In the 
CFtd group the patients deteriorated.
Neuropsychometry
Neuropsychometric test results at presentation revealed a 
pattern of general impairment in the CFtd group in contrast 
to the CPsy group. The results of the CPsy group were 
generally within normal limits. On all measures, there was 
a trend that the CPsy group outperformed the CFtd group. 
There was a trend that Full Scale, Verbal, and Performance 
IQ scores were lower in the CFtd group than the CPsy group. 
The largest difference on average was in terms of the PIQ, 
which was 20 scale points lower for the CFtd group. At a 
subtest level, the largest between-group discrepancy (of over 
6 scaled score points) was on the Comprehension subtest. The 
CFtd group showed relatively preserved performance on the 
recognition trial of the RAVLT, however their performance 
on the learning trials of this task was impaired.
Clinical proﬁ  les for FTD and psychiatric 
disorder
The above trends are summarised as patient proﬁ  les sugges-
tive of FTD and psychiatric disorder in Table 2.
Details regarding all factors from these clinical proﬁ  les 
were then obtained for the experimental group in order 
to generate putative diagnoses for the individual patients. 
Below is a summary of the experimental group details. More 
detailed clinical descriptions of each patient are presented 
in the Appendix.
Experimental group proﬁ  le
In terms of presenting complaints, these individuals reported 
a range of behavioural disturbances (eg, anger, confusion, 
avolition, social withdrawal), neurological signs (eg, seizure 
activity, pain, incontinence, sleeping difﬁ  culties), cognitive 
difﬁ  culties (eg, visuospatial, memory, attention, decision 
making, reduced reading ability), psychological symptoms (eg, 
depression, psychosis) and some were unable to provide a clear 
case history. The mean age at onset of neurological disease 
(M = 54.5) was higher than age at onset of psychiatric disease 
(M = 35.6). The majority of these individuals were medicated 
at presentation with prescriptions including anticonvulsants, 
anxiolytics, antidepressants, and neuroleptics. In terms of 
forensic issues, charges had been laid against two individuals 
(theft and murder), and one was involved in litigation.
Neurological examination of these individuals revealed a 
range of features across the 11 individuals including bradyki-
nesia (N = 1), frontal release signs (eg, grasp reﬂ  ex; N = 3), 
and abnormal pout reﬂ  ex (N = 1). In terms of bedside test-
ing, poor performances were apparent in some cases on the 
“Go-No-Go” test (N = 2), the Luria “ﬁ  st, palm, edge” test 
(N = 3), proverb interpretation (N = 1) and the alternating 
hands test (N = 3). In terms of memory, autobiographical 
memory was judged to be intact in this group, while a small 
number of individuals demonstrated difﬁ  culties with semantic 
(N = 1) and working (N = 2) memory on bedside testing.
Diagnosis of individual patients using 
clinical proﬁ  les
Best-fit analysis of the individual experimental patient 
records was conducted in comparison with the proﬁ  les dis-
played in Table 2, thus yielding putative diagnoses for the 
experimental group. Three individuals were considered to 
have FTD and eight to have psychiatric disorders.
Patient 1 (P1)
Scores on the clinical criteria suggested FTD. This patient 
had not undergone neuropsychological assessment due to 
poor comprehension of the English language leading to 
pragmatic difﬁ  culties with testing. In the absence of this data, 
we surmised P1 was more likely to have FTD.
Patient 2 (P2)
This individual scored highly on the psychiatric criteria 
for clinical information, and neuropsychological impair-
ments were thought reﬂ  ective of her complicated history, as 
opposed to the presence of FTD. P2 was classiﬁ  ed as having 
a psychiatric disorder.
Patient 3 (P3)
This patient’s clinical results were consistent with psychi-
atric disorder whilst the neuropsychometry is inconclusive. 
Therefore it was concluded that P3 was more likely to have 
a psychiatric disease.Neuropsychiatric Disease and Treatment 2007:3(5) 641
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Patients 4 and 5 (P4 and 5)
These patients both rated higher on the psychiatric scale for 
both clinical information and neuropsychometry. Both were 
concluded to have psychiatric disorders.
Patient 6 (P6)
The clinical score was equivocal in this case, but 
neuropsychometry suggested neurological disorder. On 
balance of results, this client was considered more likely to 
have FTD.
Patient 7 (P7)
Results on the clinical scale suggested psychiatric disease 
whilst the neuropsychometry was inconclusive, leading to a 
premise of psychiatric disorder.
Patient 8 (P8)
This patient scored highly on the psychiatric scale for clini-
cal data and the neuropsychometry data and was therefore 
concluded to have a psychiatric condition.
Patient 9 (P9)
This individual rated highly on the psychiatric scale for 
clinical information and weakly on the neurological scale 
for neuropsychometry. Therefore, it was considered that P9 
was more likely to fall into the psychiatric group.
Patient 10 (P10)
In this case, the clinical results were consistent with neurological 
disorder. Again, due to language barrier, no neuropsychological 
assessment was conducted. P10 was suggested to have FTD.
Table 2 Characteristic proﬁ  les of FTD and psychiatric diseases at ﬁ  rst presentation
 FTD  Psychiatric  disease
Clinical history  Referred by GP  Referred by psychiatry
  Patient unable to provide history  Patient complaint of social withdrawal
  Neurological predate psychiatric   Psychiatric predate neurological 
  symptoms (or no psychiatric symptoms)  symptoms
  No history of neuro-active medication   Patient takes/has previously taken 
  use  neuroleptics, lithium, anxiolytics or 
   hypnotics
  No relevant past medical history  Medical history includes depression, 
    head injury or ECT
  Family history of dementia, motor   Family history of psychiatric disorder 
  neurone disease or no relevant family  
 medical  history 
  No forensic or compensation issues  Positive history of forensic or 
   compensation  issues
  Family report poor memory or   Family reports of increased anger
 disinhibition 
  Professional report of communication   Professional reports of no 
 problems  abnormalities
Neurological   Abnormal gait and CNS and PNS  Essentially normal but with poor 
examination  examination. Frontal release signs  working memory on bedside testing
  present, poor performance on bedside 
  tests of executive functioning,  
  autobiograhical and semantic memory.  
  May display extrapyramidal or motor  
  neurone disease symptoms. 
Natural history  History of functional decline   Fluctuating course or no follow-up
  with/without a preceding period of  
 stability   
Neuropsychometry  Poor verbal learning, with intact   Generally, within normal limits in all 
 recognition.  areas
  Low average Intelligence. Poor verbal  
 reasoning.   Neuropsychiatric Disease and Treatment 2007:3(5) 642
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Patient 11 (P11)
This patient scored more highly on the psychiatric scale for 
clinical information and neuropsychometry. We concluded 
that P11 was more likely to have a psychiatric disease.
In summary, according to the criteria derived from analy-
sis of the control groups, P1, P6, and P10 were considered to 
have FTD, whilst P2, P3, P4, P5, P7, P8, P9, and P11 were 
more likely to be psychiatric cases. At follow-up after 5 years, 
the psychiatric patients were functionally stable, whereas the 
FTD group had deteriorated.
Discussion
Our results suggest that the majority of patients with frontal 
and/or temporal lobe atrophy on imaging suggestive of FTD 
who are referred to neurological services are more likely to 
have psychiatric diagnoses. As mentioned earlier, criteria 
for entry into the experimental group included evidence of 
selective atrophy on imaging, yet we have demonstrated 
that a large proportion of these patients were likely to have 
psychiatric disorders. What then is the signiﬁ  cance of the 
imaging data?
Recent research suggests that progressive brain structural 
changes may occur as a result of prolonged neuroleptic 
therapy (Madsen et al 1998) that may mimic the changes seen 
in FTD. It has also been suggested that the brains of schizo-
phrenic patients show various microanatomical abnormalities 
as a result of factors including oxidative stress and loss of 
trophic factors (Smythies 1998). Obviously, the relation-
ship between psychiatric disease, neuroactive medications 
and structural brain changes has yet to be fully elucidated. 
Indeed, all of these factors may be operative in this group 
of patients, including previous treatments like electro-
convulsive therapy (ECT). This would lead us to emphasise 
the importance of interpreting neuroimaging data in the light 
of clinical and neuropsychometric ﬁ  ndings, eschewing sole 
reliance on evidence of structural brain changes as evidence 
of FTD. Indeed, the consensus criteria (Neary et al 1998) do 
not consider the absence of selective atrophy as an exclusion 
factor, nor do they consider the presence of atrophy a core 
diagnostic feature.
Unfortunately, no biological marker exists to assist in the 
differentiation of these two classes of disorder. The diagno-
sis of FTD may be obvious in those families with a strong 
pedigree of dementia occurring in the presenium, but FTD is 
more likely to occur with sporadic aetiology. FTD is second 
only to Alzheimer’s disease (AD) in causes of dementia with 
onset in the presenium (Panegyres et al 2000; Hokoishi et al 
2002; Panegyres and Frencham 2007). At post-mortem, up 
to one-ﬁ  fth of dementia deaths are retrospectively attributed 
to FTD (Lebert et al 1998).
Common characteristics of FTD include onset of behav-
ioural changes predating cognitive decline (Pasquier et al 
1998), dietary changes, hypersexuality and bizarre compul-
sions (Miller et al 1995). Differing predominant symptom 
spectrums have been found to be associated with FTD 
affecting one hemisphere to a greater extent, with language 
changes associated with left-sided disease and aggression 
and antisocial behaviours associated with a preponderance of 
disease on the right (Mychack et al 2001). Despite the com-
monality of this condition, FTD remains under-diagnosed 
due to confusion with other forms of dementia and with 
psychiatric disorders. The subtypes of FTD have been found 
to be indistinguishable by neuropsychological examination, 
behavioural abnormalities and psychiatric symptoms as 
assessed by the Neuropsychiatric Inventory with the excep-
tion of aphasia in primary progressive aphasia (Ikeda and 
Tanabe 2000).
Evidence from the literature suggests FTD may be dif-
ferentiated from AD on the basis of the presenting symptoms 
with disinhibition, social awkwardness, passivity and loss of 
executive function seen in the former and memory loss more 
commonly found in the latter (Lindau et al 2000). In the later 
stages of FTD, stereotypic eating behaviour and further loss 
of social graces have been found to be discriminatory factors, 
regardless of disease severity (Bozeat et al 2000).
While various modalities of neuroimaging have been 
found to be of merit in the distinction between other neuro-
logical pathologies and depression (Olazartan et al 2002) one 
should be wary of excessive reliance on these techniques, and 
imaging data does not play a role in the consensus criteria 
for FTD (Neary et al 1998).
Diagnosis of FTD is traditionally reliant upon the devel-
opment of characteristic behaviours over time (Kertesz et al 
2000). This focus on behavioural features may partially 
explain the trend of FTD being misdiagnosed as a psychi-
atric condition in the early stages of the disease (Olazaran 
et al 2002).
While we propose that it is possible to distinguish psychi-
atric disorders from FTD on the basis of clinical information 
gathered at ﬁ  rst presentation irrespective of imaging results, 
there are several potential limitations to this study. The 
sample sizes of the control and experimental groups were 
small. While we have not conducted statistical analysis, 
and have reported on trends and patterns of symptoms, our 
conclusions would be strengthened by increased sample size 
and replication of ﬁ  ndings. Relating to the frequency of signs Neuropsychiatric Disease and Treatment 2007:3(5) 643
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and symptoms, and more speciﬁ  cally to neuropsychometric 
results, future research (incorporating larger sample sizes) 
could analyse the data statistically, and generate effect sizes 
associated to the characteristics in the proﬁ  les generated. 
Finally, while many of the patients previously described 
underwent comprehensive speech and language assessments, 
the results were not incorporated into this study. In light of 
the communicative dysfunction that has been reported to be 
associated with FTD in particular, it would be clinically use-
ful to add this information to the characteristic proﬁ  les.
In this paper we have attempted to provide the clinician 
with proﬁ  les of data that can be collected at ﬁ  rst presenta-
tion in order to differentiate between two difﬁ  cult groups 
of patients. We suggest that with further experience and 
research, these proﬁ  les should be further reﬁ  ned to achieve 
better representation of the patient population, and will be 
augmented by the future development of biological markers 
including genomic analysis (Panegyres and Zaﬁ  ris-Toufexis 
2002). Functional brain imaging in the form of SPECT and 
PET scanning might be additional aids in the differential 
diagnosis of FTD from psychiatric disease. Unfortunately 
not all clinicians have access.
The results also suggest a subgroup of patients with 
psychiatric disease who have frontal and/or temporal lobe 
atrophy on neuroimaging.
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This woman was referred by psychiatry and neurology. 
While she was unable to provide a history, it was possible to 
ascertain that onset of psychiatric symptoms was 59 years and of 
neurological symptoms was 62 years. She had been prescribed 
neuroleptic medication for 3 years and had a history of depression 
and psychosis. Her family reported personality changes and 
incontinence, while professional reports noted decreased 
motivation and speech output. On neurological examination she 
displayed bradykinesia, bilateral grasp reﬂ  ex and extrapyramidal 
symptoms were present. Neuropsychological assessment was 
not possible due to language constraints. Symptomatology had 
been stable for 3 years.
Patient 2
This woman was referred by psychiatry due to atrophy 
on imaging. She reported increased anger, with onset of 
psychiatric symptoms at age 29, and onset of neurological 
symptoms at age 56. She reported having been prescribed 
neuroleptic, antidepressant and anxiolytic medication, but 
could not specify how long she had taken these medications 
for. There was a family history of personality disorder and 
learning disability. Professionals report indicated anger, 
reduced libido and generalised affective changes. Her neuro-
logical examination was normal except for poor performance 
on the go-no-go and alternating hands sequences tests. On 
neuropsychological assessment, she demonstrated poor ver-
bal ﬂ  uency and verbal learning, with intact recognition. Her 
Full Scale IQ was in the Extremely Low range. Symptoms 
had been stable for 2 years but had subsequently deteriorated 
over a 2 year period.
Patient 3
This woman was referred by neurology due to atrophy on 
imaging. Her presenting complaints included increased 
anger, confusion, seizure activity, poor memory and visuo-
spatial difﬁ  culties. The onset of psychiatric symptoms was 
28 years, and of neurological symptoms was 52 years. While 
she had no history of psychoactive medication, her relevant 
medical history included that she had undergone ECT and 
had required hospitalisation and had incurred two mild head 
injuries. There was a positive family history of depression in a 
ﬁ  rst degree relative. Her family reported that she had become 
more socially withdrawn and that her sleeping patterns had 
been interrupted. No abnormalities were noted on neurologi-
cal examination. Her neuropsychological proﬁ  le was gener-
ally within normal limits, apart from a poor performance on 
a visual recall task. Symptoms were stable for 2 years, but 
subsequently deteriorated over a 2-year period.
Patient 4
This man was referred by psychiatry and neurology. His 
presenting complaints included depression, pain and poor 
short-term memory. Ages at onset of psychiatric and neu-
rological symptoms were similar, being 51 and 52 years 
respectively. He had been taking antidepressant medication 
for one year and anxiolytic medication for 6 months. He had 
a history of depression requiring hospitalisation and his fam-
ily reported increased depression, poor memory and social 
withdrawal. Professional reports noted depression, disinhibi-
tion and abulia. There were no abnormalities on neurologi-
cal examination, however neuropsychological examination 
demonstrated impaired verbal learning and recognition and 
poor verbal ﬂ  uency. In terms of the history of symptoms, a 
previous 2 year period of deterioration in functioning was 
followed by a 2 year period of stability.
Patient 5
This man was referred by psychiatry and neurology. His 
presenting complaints included depression, decreased atten-
tion and concentration, incontinence, psychosis, ECT and 
changes in sleeping pattern. The age of onset of neurological 
symptoms was 49 years, while the age of psychiatric symp-
toms was 51 years. He had taken neuroleptic, antidepressant 
and anxiolytic medication for a period of six months. Rel-
evant past medical history included depression, psychosis 
(requiring hospitalisation) and ECT. There was a history of 
psychiatric disorder (nature unknown) in one ﬁ  rst-degree 
family member. Professional report noted abulia, impaired 
frontal or executive functioning and frontal lobe syndrome. 
Neurological examination revealed poor performance on 
the Luria “ﬁ  st, palm, edge” test and the alternating hands 
test. On neuropsychological examination, he demonstrated 
intellectual functioning in the Extremely Low range. Symp-
tomatology had been stable for 3 years.
Patient 6
This man was referred by psychiatry and neurology due to 
atrophy on imaging. His presenting complaints were depres-
sion, decreased motivation and psychosis. His psychiatric 
symptoms were longstanding (onset at 16 years). He was 
52 years old at the time of onset of neurological symptoms. 
He had been on antidepressant and neuroleptic mediation 
for 10 years. He reported a history of psychosis (requiring 
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report noted poor short-term memory and a frontal lobe 
syndrome. On neurological examination, bilateral grasp and 
pout reﬂ  exes were present. Performance on the go-no-go test, 
Luria “ﬁ  st, palm, edge” test and proverb interpretation was 
found to be poor. On neuropsychological examination, his 
copy and recall of a geometric ﬁ  gure was impaired, as was 
his verbal learning and memory, while his recognition was 
intact. Verbal ﬂ  uency was markedly poor, in the context of 
a Low Average Full Scale IQ. His condition had remained 
stable for 3 years.
Patient 7
This woman was referred by her general practitioner due 
to signs suggestive of a neurodegenerative process. She 
complained of poor short-term memory, reduced decision 
making ability and social withdrawal. The age of onset of 
neurological symptoms was 66 years. She had been on antide-
pressant medication for an unknown period of time, and had 
a history of depression. There was a family history of alcohol 
dependency in a ﬁ  rst-degree relative. The professional report 
noted fronto-temporal dysfunction. Neurological examina-
tion was normal, except for poor working memory on bedside 
testing. Neuropsychological assessment revealed markedly 
impaired recall of visual and verbal information, and poor 
verbal recognition. While summary scores were not avail-
able, her performance on WAIS-III subtests tended to fall 
in the average range. There was a 2 year history of decline 
in her status.
Patient 8
This man was referred by psychiatry and neurology. His was 
unable to provide a history. Onset of psychiatric symptoms 
was 31 years, and 55 years for neurological symptoms. 
He had taken neuroleptic and lithium medication for an 
unknown time period. He had been diagnosed with bipolar 
affective disorder. Professional report noted the presence of 
a frontal lobe syndrome, however neurological examination 
was normal. His neuropsychological proﬁ  le was essentially 
within normal limits, apart from a poor performance on a 
task of verbal ﬂ  uency. He had a 2 year history of decline 
in status.
Patient 9
This woman was referred by psychiatry and neurology due to 
atrophy on imaging. Her main complaint was of depression. 
She was 33 years old at onset of psychiatric symptoms, and 
52 years at onset of neurological symptoms. She had taken 
anticonvulsant, neuroleptic and antidepressant medication 
for an undeﬁ  ned time period. She had a complex background 
including bipolar affective disorder, psychosis, alcohol 
dependency requiring hospitalisation and ECT. There was 
a history of alcohol dependency in a ﬁ  rst-degree family 
member. Her family reported poor memory, and professional 
report commented on changed in affect and frontal lobe syn-
drome. Her neurological examination was normal, however 
neuropsychological assessment revealed poor delayed visual 
and verbal recall, in the context of intact verbal recognition. 
Her status was stable for 3 years.
Patient 10
This woman was referred by psychiatry and neurology 
with presenting complaints of poor memory and difﬁ  culty 
reading. She had been 35 years old at onset of psychiatric 
symptoms and 62 at onset of neurological symptoms. She 
had taken neuroleptic and lithium medication for 2 years and 
antidepressant medication for an unspeciﬁ  ed time. She had 
a history of depression requiring hospitalisation and ECT. 
There was a history of motor neurone disease in ﬁ  ve family 
members and of depression and bipolar in two others. Her 
family reported confusion, incontinence, delusions, poor 
short-term memory, disinhibition, decreased motivation 
and wandering behaviour. Professional report noted poor 
memory, abulia, confusion, depression and decreased verbal 
ﬂ  uency. One neurological examination, the bilateral grasp 
reﬂ  ex was present and the performed poorly on the Luria 
“ﬁ  st, palm, edge” test, and bedside tests of working and 
semantic memory. She did not undergo neuropsychological 
assessment due to language difﬁ  culties. She had a 2 year 
stable history.
Patient 11
This man was referred by psychiatry due to atrophy on imag-
ing. His presenting complaints included poor short-term 
memory, social withdrawal, decreased attention and concen-
tration and depression. The onset of psychiatric symptoms 
was 25 years, and 34 for neurological symptoms. He had 
taken antidepressant, neuroleptic and anxiolytic medica-
tion for one year. He had a history of mild had injury, post 
traumatic stress disorder and personality disorder along with 
anxiety, requiring hospitalisation. Relevant forensic history 
included a charge of theft. His family reported poor hygiene, 
depression and difﬁ  culty following instructions. Professional 
report noted personality disorder. Neurological examination 
was normal, and neuropsychological examination revealed 
intellectual functioning in the Average range. He had a tonth 
stable history of symptoms.